COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Michelin | Déclaration du nombre total des droits de vote et du nombre d'actions composant le capital social
Déclaration du nombre total des droits de vote et du nombre d'actions de la Compagnie Générale des Établissements Michelin, avec coordonnées de contact pour investisseurs et actionnaires -
-
COMMUNIQUÉ DE PRESSE
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation
MIRA Pharmaceuticals to acquire SKNY Pharmaceuticals, enhancing MIRA pipeline with oral drug SKNY-1 for weight loss and nicotine cravings reversal. Shareholders approve merger with $30 million valuation -
-
COMMUNIQUÉ DE PRESSE
Nepra Foods Issues Letter from CEO
Nepra Foods CEO Billy Hogan expresses gratitude towards shareholders for support and shares company achievements. Revenue increased by 50.3% and net loss reduced by over 302% in fiscal year 2025. Focus on profitability and debt reduction highlighted -
COMMUNIQUÉ DE PRESSE
Progress in clinical development for Alzheimer´s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modul
Galimedix successfully completes Phase 1 study with GAL-101, a small molecule targeting amyloid beta in Alzheimer's disease. Phase 2 trial planned
